跳至主要内容
临床试验/NCT06099808
NCT06099808Enrolling By Invitation不适用

Randomized Evaluation of Audit and Feedback Intervention to Promote Pharmacist Heart Failure Medication Titration in Veterans Affairs Sierra Pacific Network

Stanford University2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2023年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
110
试验地点
2
主要终点
Number of monthly heart failure medication adjustment encounters

研究概览

简要总结

This is a randomized quality improvement project to evaluate the impact of an audit and feedback intervention to motivate pharmacists to provide heart failure (HF) medication management to patients in the Veterans Health Administration (VHA) Sierra Pacific region (VISN 21). The results of this project could provide guidance for how to successfully scale a pharmacist-based HF remote management program in the VHA more broadly.

Pharmacists providing clinical care as part of Patient Aligned Care Team (PACT) within VHA VISN 21 will be included. Pharmacists will be randomized to one of 3 arms in a 1:1:2 ratio: (1) monthly audit and feedback of HF medication titration activities (AF) vs. (2) educational resources and monthly notification of HF medication titration actions in addition to a list of potential patients for HF optimization (AF+) vs. (3) usual care without audit and feedback (UC). Pharmacists across all three arms will be given access to shared educational resources on HF pharmacist care and educational webinars. Six months after the intervention, rates of pharmacist HF medication titration encounters will be compared among the 3 groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical pharmacists in the Veterans Health Administration that provide Patient Aligned Care Team (PACT) care in VA Sierra Pacific Network (VISN 21)

排除标准

  • Excluded per pharmacist supervisor decision

结局指标

主要结局

Number of monthly heart failure medication adjustment encounters

时间窗: 2 months post-randomization to 6 months post-randomization

Encounters in which pharmacist adjusted heart failure medications

次要结局

  • Beta-blocker therapy(At 6 months post randomization)
  • Number of new patients with pharmacist HF management(Within 6 months post-randomization)
  • Guideline medical therapy score(At 6 months post randomization)
  • Renin-angiotensin system inhibitor (RASI) therapy(At 6 months post randomization)
  • Percentage of heart failure patients with medication management by pharmacist(Within 6 months post-randomization)
  • Angiotensin receptor neprilysin inhibitor (ARNI) therapy(At 6 months post randomization)
  • Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) therapy(At 6 months post randomization)
  • Mineralocorticoid receptor antagonist (MRA) therapy(At 6 months post randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul A. Heidenreich

Professor of Medicine

Stanford University

研究点 (2)

Loading locations...

相似试验